Twist Bioscience Corp’s recent filing unveils that its Chief Executive Officer Leproust Emily M. unloaded Company’s shares for reported $37057.0 on Apr 02 ’24. In the deal valued at $32.74 per share,1,132 shares were sold. As a result of this transaction, Leproust Emily M. now holds 514,149 shares worth roughly $16.77 million.
Then, Finn Patrick John sold 492 shares, generating $16,106 in total proceeds. Upon selling the shares at $32.74, the President and COO now owns 178,380 shares.
Before that, Banyai William sold 327 shares. Twist Bioscience Corp shares valued at $10,705 were divested by the See Remark at a price of $32.74 per share. As a result of the transaction, Banyai William now holds 345,986 shares, worth roughly $11.28 million.
Goldman upgraded its Twist Bioscience Corp [TWST] rating to a Buy from a a Neutral in a research note published on January 17, 2024; the price target was increased to $45 from $25. A number of analysts have revised their coverage, including Berenberg’s analysts, who began to cover the stock in late September with a ‘”a Buy”‘ rating. Scotiabank began covering TWST with “Sector outperform” recommendation on January 05, 2023. Evercore ISI revised its rating on January 03, 2023. It rated TWST as “an Outperform” which previously was an “an In-line”.
Price Performance Review of TWST
On Friday, Twist Bioscience Corp [NASDAQ:TWST] saw its stock jump 1.97% to $32.61. Over the last five days, the stock has lost -4.95%. Twist Bioscience Corp shares have fallen nearly -11.53% since the year began. Nevertheless, the stocks have risen 136.82% over the past one year. While a 52-week high of $43.21 was reached on 02/15/24, a 52-week low of $11.46 was recorded on 04/05/24. SMA at 50 days reached $36.25, while 200 days put it at $26.78. A total of 0.63 million shares were traded, compared to the trading of 0.69 million shares in the previous session.
Levels Of Support And Resistance For TWST Stock
The 24-hour chart illustrates a support level at 31.52, which if violated will result in even more drops to 30.42. On the upside, there is a resistance level at 33.40. A further resistance level may holdings at 34.18. The Relative Strength Index (RSI) on the 14-day chart is 39.53, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -1.34, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 75.48%. Stochastics %K at 15.10% indicates the stock is a buying.
How much short interest is there in Twist Bioscience Corp?
A steep rise in short interest was recorded in Twist Bioscience Corp stocks on Mar 15, 2024, dropping by -0.35 million shares to a total of 12.01 million shares. Yahoo Finance data shows the prior-month short interest on Feb 15, 2024 was 12.36 million shares. There was a decline of -2.91%, which implies that there is a negative sentiment for the stock. In spite of short shares comprising just 27.24% of the overall stock float, the days-to-cover ratio (short ratio) fell to 14.44.
